U.S. markets close in 6 hours 17 minutes
  • S&P 500

    4,554.12
    +4.34 (+0.10%)
     
  • Dow 30

    35,745.12
    +142.04 (+0.40%)
     
  • Nasdaq

    15,175.32
    -40.38 (-0.27%)
     
  • Russell 2000

    2,296.18
    +6.42 (+0.28%)
     
  • Crude Oil

    83.55
    +1.05 (+1.27%)
     
  • Gold

    1,808.00
    +26.10 (+1.46%)
     
  • Silver

    24.61
    +0.44 (+1.84%)
     
  • EUR/USD

    1.1650
    +0.0019 (+0.16%)
     
  • 10-Yr Bond

    1.6700
    -0.0060 (-0.36%)
     
  • GBP/USD

    1.3793
    -0.0002 (-0.02%)
     
  • USD/JPY

    113.7880
    -0.2000 (-0.18%)
     
  • BTC-USD

    63,320.95
    -2,141.88 (-3.27%)
     
  • CMC Crypto 200

    1,502.05
    -0.98 (-0.07%)
     
  • FTSE 100

    7,214.07
    +23.77 (+0.33%)
     
  • Nikkei 225

    28,804.85
    +96.27 (+0.34%)
     

Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

·6 min read
Can Last Year's Biggest Vaccine Stocks Crush the Market Again?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Coronavirus vaccine stocks were the biggest investment theme of 2020. Since, two biotech companies -- Moderna (NASDAQ: MRNA) and BioNTech -- actually have commercialized their vaccines. Let's take a look at where they're at with vaccine programs -- and whether they're on track to beat the market in the second half.